Magis Farmaceutici, collaborates with the scientific community with a continuous exchange of knowledge, which has led to a benefit and protection of patients’ health, in line with the codes and regulations that govern our sector.
It shares the principles of transparency indicated by Assogenerici and by EFPIA - European Federation of Associations and Pharmaceutical Industries.
Therefore, the publication of data transferring value is an opportunity for us to strengthen transparency towards citizens and institutions.
Magis Farmaceutici under the EFPIA code on transparency, publishes the transfers of value granted to Healthcare Professionals and Health Organizations, linked to the development and marketing of medicines for human use (with a medical prescription requirement).
Once again we want Magis Farmaceutici to be recognized by all our interlocutors as a reliable company, able to promote and adopt at all levels transparent behaviors that are consistent with the rules and regulations, and with a sense of responsibility for its key role in the pharmaceutical sector.
Based on the rules of the Code on Disclosure of Transfers of Value from Pharmaceuticals to Healthcare Professionals and Healthcare Organizations, related to transparency on transfers of value between pharmaceutical companies, Health Professionals and Health Organizations indicated by EFPIA, also implemented by the Code of Ethics of Assogenerici, our company is committed to making public the data related to these transfers of value, with a view to transparency and full traceability of the operations carried out, every year and starting from 2017 (first publication 30 June 2018). Magis Farmaceutici will publish the transfers of value on an aggregate basis, that is anonymously, without mentioning the personal data (name, address or other data of the interested party).
From 30 June 2018 on the Magis Farmaceutici websites, it is possible to view the details of the economic transactions that took place in 2017 against Healthcare Professionals and Healthcare Organizations.
In the case of Health Operators, these are fees for participation in conventions and congresses and expenses for consultancy and professional services regulated by a specific contract.
In the case of health organizations, donations and contributions, both in cash and in kind, are sponsored by scientific events of high educational value, fees for consultancy and professional services resulting from a written contract between Magis Farmaceutici and Institutions, Organizations or Associations .
Regarding the value transfers at the corporate level for Research and Development, only are published the costs relating to pre-clinical, clinical and observational studies paid directly or indirectly to Healthcare Professionals and Health Organizations, both in Italy and abroad (therefore only a minimum part of the amount indicated refers to Healthcare Professionals and Healthcare Organizations located in Italy).
For information on the regulation introduced by the “Code on the transparency of transfers of value between pharmaceutical companies, health workers and health organizations”, please visit the website www.farmindustria.it (Deontological Code section).
Publication on an individual or aggregate basis?
The transfers of value to Healthcare Professionals will be published on an individual or aggregate basis.
The EFPIA Transparency Code is a voluntary commitment, the privacy laws of European countries, including Italy, allow the publication of individual data only with the consent of the Health Professional. If the Health Professional does not allow the disclosure of individual data, his transfers of value will be reported on an aggregate basis.
The transfers of value concerning the “Research and Development” sector will always be reported on an aggregate basis as regulated by the EFPIA Transparency Code.